---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-040329"
form_type: "8-K"
ticker: "IDXG"
cik: "0001054102"
company_name: "INTERPACE BIOSCIENCES, INC."
filed_at: "2026-08-27T12:30:22+00:00"
generated_at: "2026-08-27T12:35:23.896503+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Interpace Biosciences announces 1-for-5 reverse stock split to support Nasdaq uplisting

## Summary
- 1-for-5 reverse stock split effective 12:01 a.m. ET Aug 27, 2026; shares reduced from ~27.7M to ~5.5M.
- Ticker temporarily changes to IDXGD for 20 trading days; new CUSIP 46062X402; par value unchanged at $0.01.
- Split intended to meet Nasdaq minimum bid price requirement; company also needs $15M market value of unrestricted public shares.
- Proportional adjustments to outstanding stock options, RSUs, and equity plan shares; fractional shares rounded up.
- CEO Tom Burnell: split is key part of strategy to uplist to Nasdaq and attract broader investor base.

## SEC filing metadata
- accession: 0001493152-26-040329
- form_type: 8-K
- ticker: IDXG
- cik: 0001054102
- company_name: INTERPACE BIOSCIENCES, INC.
- filed_at: 2026-08-27T12:30:22+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1054102/000149315226040329/0001493152-26-040329-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1054102/000149315226040329/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-040329
- JSON: https://secwatch.observer/filing/0001493152-26-040329.json
- Plain text: https://secwatch.observer/filing/0001493152-26-040329.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.